Table 1 Summary of Clinicopathological Factors and Methylation in Clinical Cancers

Sample No.	Age	Clinical stage	Gleason score	AR expression	AR methylation
					Region 1	Region 2	Region 3
Primary prostate cancers
#P1	61	C	7	H	U	U	U
#P2	77	B2	5	N	M	M	M
#P3	75	C	5	H	M	M	M
#P4	60	C	9	H	U	U	U
#P5	60	B1	9	H	U	U	U
#P6	66	B1	7	H	U	U	U
#P7	62	B1	3	H	U	U	U
#P8	55	B1	9	H	M	U	U
#P9	61	B1	8	H	M	U	U
#P10	64	C	9	H	U	U	U
Hormone-refractory tumors
#R1	84	D2	9	ND	U	U	U
#R2	66	D2	8	ND	M	M	M
#R3	65	D2	8	ND	U	U	U
#R4	68	D2	7	ND	M	M	M
#R5	79	D2	9	ND	U	U	U
#R6	78	D2	9	ND	U	U	U
#R7	69	D2	9	ND	U	U	U
#R8	67	D2	7	ND	U	U	U
#R9	71	D2	9	ND	U	U	U
#R10	75	D2	7	ND	U	U	U
#R11	80	D2	9	ND	M	M	M
#R12	89	D2	8	ND	M	M	M
#R13	81	D2	9	ND	U	U	U
#R14	79	D2	8	ND	U	U	U

M, methylated; U, unmethylated; H, heterogeneous expression; N, no expression; AR, androgen receptor; ND, not determined.

Quick links

Search